Daewoong to announce positive results for DWP05195, chronic intractable painkiller

Published: 2010-11-24 06:57:00
Updated: 2010-11-24 06:57:00
Daewoong Pharmaceutical says it has completed Phase 1 local clinical study of DWP05195, neuropathic painkiller, in 120 healthy volunteers with neuropathy.

"We are extremely pleased with the results of this 120 healthy volunteers Phase I clinical trial in Korea which clearly demonstrated an exc...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.